Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

This study is testing a new drug called DKF-MA102 in men with prostate cancer. The study aims to evaluate how safe the drug is and how well it works as a treatment, particularly in men who still have active testosterone levels. **You may be eligible if...** - You are a male aged 19 or older with a confirmed prostate cancer diagnosis - Your testosterone level is above 150 ng/dL (meaning you have not had full hormone suppression) - Your overall health is adequate (ECOG 0–2) - Your expected survival is at least 1 year **You may NOT be eligible if...** - You have had prior treatment that would interfere with this drug - You have significant heart, liver, or kidney problems - You have active serious infections Talk to your doctor to see if this trial is right for you.